Robin S B Williams Selected Research

octanoic acid (caprylic acid)

1/2021	Using Dictyostelium to Advance Our Understanding of the Role of Medium Chain Fatty Acids in Health and Disease.
1/2021	K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy.
1/2015	Seizure control by derivatives of medium chain fatty acids associated with the ketogenic diet show novel branching-point structure for enhanced potency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robin S B Williams Research Topics

Disease

18	Epilepsy (Aura) 10/2021 - 06/2007
15	Bipolar Disorder (Manic Depressive Psychosis) 01/2018 - 04/2004
11	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 04/2014
7	Drug Resistant Epilepsy 01/2021 - 12/2013
6	Neoplasms (Cancer) 01/2021 - 09/2006
5	Seizures (Absence Seizure) 01/2022 - 02/2014
3	Migraine Disorders (Migraine) 07/2011 - 06/2007
2	Starvation 01/2018 - 01/2011
1	Ketosis 01/2021
1	Multiple Sclerosis 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Dementia (Dementias) 01/2018
1	Insulin Resistance 01/2018
1	Nervous System Diseases (Neurological Disorders) 03/2017
1	Hypercholesterolemia 02/2016
1	Parkinson Disease (Parkinson's Disease) 02/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016
1	Lewy Body Disease (Lewy Body Dementia) 02/2016
1	Hypothermia 11/2015
1	Shock 11/2015
1	Hypoxia (Hypoxemia) 11/2015
1	Hypercapnia 11/2015
1	Status Epilepticus (Complex Partial Status Epilepticus) 08/2015
1	Congenital Abnormalities (Deformity) 12/2013
1	Vomiting 01/2011
1	Mental Disorders (Mental Disorder) 06/2010
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2009
1	Lissencephaly 09/2006
1	Mood Disorders (Mood Disorder) 05/2002

Drug/Important Bio-Agent (IBA)

17	Valproic Acid (Depakote)FDA LinkGeneric 01/2018 - 05/2002
8	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2012
7	LithiumIBA 01/2018 - 05/2002
6	Triglycerides (Triacylglycerol)IBA 01/2021 - 06/2013
6	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2017 - 10/2009
5	Inositol (Myoinositol)IBA 03/2017 - 05/2002
4	decanoic acid (capric acid)IBA 01/2021 - 02/2016
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2005
4	Pharmaceutical PreparationsIBA 10/2017 - 09/2006
3	AMPA Receptors (AMPA Receptor)IBA 01/2022 - 02/2016
3	KetonesIBA 10/2021 - 02/2016
3	octanoic acid (caprylic acid)IBA 01/2021 - 01/2015
3	Anticonvulsants (Antiepileptic Drugs)IBA 08/2015 - 07/2011
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2020
2	CannabidiolIBA 01/2021 - 01/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 01/2020
2	perampanelIBA 11/2018 - 02/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 02/2016
2	Peptides (Polypeptides)IBA 01/2018 - 02/2016
2	PresenilinsIBA 12/2016 - 04/2014
2	EnzymesIBA 01/2016 - 06/2010
2	Pentylenetetrazole (Metrazol)IBA 01/2015 - 02/2014
2	Neuroprotective AgentsIBA 06/2013 - 09/2006
1	Dietary Fats (Dietary Fat)IBA 01/2021
1	SugarsIBA 01/2021
1	trans-sodium crocetinate (crocetin)IBA 01/2020
1	CarbonIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Methionine (L-Methionine)FDA Link 01/2020
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2019
1	DiglyceridesIBA 01/2018
1	FatsIBA 01/2018
1	CurcuminIBA 01/2018
1	Diacylglycerol KinaseIBA 01/2018
1	Biological ProductsIBA 01/2018
1	DiarylheptanoidsIBA 01/2018
1	Protein Kinase CIBA 01/2018
1	Inositol PhosphatesIBA 03/2017
1	PrionsIBA 02/2016
1	cysteine string proteinIBA 02/2016
1	Cholesterol Esters (Cholesteryl Esters)IBA 02/2016
1	LipidsIBA 02/2016
1	SynaptophysinIBA 02/2016
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 02/2016
1	SynucleinsIBA 02/2016
1	Ionotropic Glutamate ReceptorsIBA 02/2016
1	D-myo-inositol-3-phosphate synthaseIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 11/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2015
1	ciglitazoneIBA 11/2015
1	Kainic Acid (Kainate)IBA 02/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2014
1	GABA-A Receptor AntagonistsIBA 02/2014
1	Phosphotransferases (Kinase)IBA 02/2011
1	NitrogenIBA 01/2011
1	EmeticsIBA 01/2011
1	Indicators and Reagents (Reagents)IBA 01/2011
1	myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA 06/2010
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 09/2006
1	Peptide Hydrolases (Proteases)FDA Link 04/2004
1	Glycogen Synthase KinasesIBA 05/2002
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2002

Therapy/Procedure

9	Ketogenic Diet 10/2021 - 06/2013
3	Therapeutics 01/2018 - 06/2007
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 01/2018
1	Investigational Therapies (Experimental Therapy) 08/2015